In the version of the article originally published, the clinical trial number NCT05668091 was missing the final digit in the first paragraph of the “Biomarker and therapeutic targets for PASC clinical trials” section. The error has been corrected in the HTML and PDF versions of the article.
Author informationAuthors and Affiliations
PolyBio Research Foundation, Medford, MA, USA
Amy D. Proal, Michael B. VanElzakker & Katie Bach
Division of Neurotherapeutics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Michael B. VanElzakker
Dept of Infectious Diseases and Unit of Post-Covid Huddinge, Karolinska University Hospital, Stockholm, Sweden
Soo Aleman
Nonresident Senior Fellow, Brookings Institution, Washington, DC, USA
Katie Bach
Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA
Brittany P. Boribong, Alessio Fasano & Lael M. Yonker
Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA, USA
Brittany P. Boribong, Alessio Fasano & Lael M. Yonker
Harvard Medical School, Boston, MA, USA
Brittany P. Boribong, William Eimer, Alessio Fasano, Rudolph E. Tanzi & Lael M. Yonker
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden
Marcus Buggert
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, UPENN, Philadelphia, PA, USA
Sara Cherry
Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
Daniel S. Chertow
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Daniel S. Chertow
Department of Respiratory Medicine, University Hospital Llandough, Cardiff University School of Medicine,
Continue reading on Nature
